Your Article Summary
See Latest ArticlesThyroid metastasis of clear cell renal carcinoma: Report of a case
Diagnostic Cytopathology, 06/19/09
Rizzo M et al. - The diagnosis of metastatic disease, although difficult clinically and pathologically, should be suspected in patients with a clinical history of cancer, particularly in case of renal cell carcinoma, but fine-needle aspiration cytology can provide the clue for diagnosis.
Related Articles
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 70%
Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma
The Journal of Urology, 11/23/09
Relevance Score: 69%
Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09
Relevance Score: 69%
Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey
European Journal of Cancer Care, 10/22/09
Relevance Score: 69%
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 69%
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimotos thyroiditis
Histopathology, 12/04/09
Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference
Histopathology, 12/04/09
Clinical inquiry: What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?
The Journal of Family Practice, 12/03/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09